186
Participants
Start Date
June 21, 2016
Primary Completion Date
July 31, 2020
Study Completion Date
July 31, 2020
MM09 Mannosylated 5.000 subcutaneous
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 5.000 MTU (Mannosylated Therapeutic Units)/ml subcutaneous
MM09 Mannosylated 10.000 subcutaneous
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 10.000 MTU (Mannosylated Therapeutic Units)/ml subcutaneous
MM09 Mannosylated 30.000 subcutaneous
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 30.000 MTU (Mannosylated Therapeutic Units)/ml subcutaneous
MM09 Mannosylated 50.000 subcutaneous
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 50.000 MTU (Mannosylated Therapeutic Units)/ml subcutaneous
MM09 Mannosylated 5.000 sublingual
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 5.000 MTU (Mannosylated Therapeutic Units)/ml sublingual
MM09 Mannosylated 10.000 sublingual
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 10.000 MTU (Mannosylated Therapeutic Units)/ml sublingual
MM09 Mannosylated 30.000 sublingual
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 30.000 MTU (Mannosylated Therapeutic Units)/ml sublingual
MM09 Mannosylated 50.000 sublingual
Mixture of the following mites: Dermatophagoides pteronyssinus and Dermatophagoides farinae, allergen extract with a concentration of 50.000 MTU (Mannosylated Therapeutic Units)/ml sublingual
Subcutaneous placebo
Comparison between placebo and active group
Sublingual placebo
Comparison between placebo and active group
Hospital Universitari de Castelló, Castellon
Hospital de La Plana, Vila-real
Hospital Arnau de Vilanova, Valencia
Hospital Universitario Doctor Peset, Valencia
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Adults, Valencia
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE child, Valencia
Hospital Lluis Alcanyis de Xátiva, Xátiva
Hospital de Manises, Manises
Hospital General Universitario de Elche, Elche
Hospital Del Vinalopo, Elche
Hospital General Universitario de Elda-Virgen de La Salud, Elda
Hospital Vega Baja Orihuela, Orihuela
Hospital General Universitario de Alicante, Alicante
Hospital Vithas Internacional Medimar, Alicante
Lead Sponsor
Inmunotek S.L.
INDUSTRY